Bikam Pharmaceuticals Inc.
Records under this name other than patents Bikam Pharmaceuticals Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 7 of 7 · Back to Bikam Pharmaceuticals Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,353,063 | Opsin-binding ligands, compositions and methods of use Lapsed on the fee record Ended May 31, 2024 · USPTO record | Lapsed on the fee record | Ended May 31, 2024 | USPTO record |
| US 9,133,082 | Opsin-binding ligands, compositions and methods of use Lapsed on the fee record Ended Sep 15, 2023 · USPTO record | Lapsed on the fee record | Ended Sep 15, 2023 | USPTO record |
| US 10,040,749 | Opsin-binding ligands, compositions and methods of use Lapsed on the fee record Ended Aug 7, 2022 · USPTO record | Lapsed on the fee record | Ended Aug 7, 2022 | USPTO record |
| US 9,757,370 | Opsin-Binding Ligands, Compositions and Methods of Use Lapsed on the fee record Ended Sep 12, 2021 · Medium confidence | Lapsed on the fee record | Ended Sep 12, 2021 | Medium confidence |
| US 9,562,022 | Opsin-Binding Ligands, Compositions and Methods of Use Lapsed on the fee record Ended Feb 7, 2021 · High confidence | Lapsed on the fee record | Ended Feb 7, 2021 | High confidence |
| US 9,499,464 | Opsin-binding ligands, compositions and methods of use Lapsed on the fee record Ended Nov 22, 2020 · USPTO record | Lapsed on the fee record | Ended Nov 22, 2020 | USPTO record |
| US 9,457,004 | Opsin-binding ligands, compositions and methods of use Lapsed on the fee record Ended Oct 4, 2020 · USPTO record | Lapsed on the fee record | Ended Oct 4, 2020 | USPTO record |